SIGI
GMAB icon

Susquehanna International Group (Ireland)’s Genmab GMAB Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,300
Closed -$335K – 74
2022
Q2 		$335K Buy
+10,300
New +$334K 0.08% 59

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Susquehanna International Group (Ireland)'s GMAB Position: Q3 2022 in Review

Susquehanna International Group (Ireland) sold out of Genmab (GMAB) in Q3 2022, closing a stake of 10,300 shares — an estimated $335K sold.

Susquehanna International Group (Ireland) first reported a position in GMAB in Q2 2022 and held it in 1 quarter. The position peaked at $335K in Q2 2022. 194 funds tracked by Wall St. Rank hold GMAB as of Q3 2022.

  • Susquehanna International Group (Ireland) reported no remaining Genmab position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group (Ireland) sold 10,300 Genmab shares in Q3 2022, an estimated $335K.
  • Susquehanna International Group (Ireland) first reported a position in Genmab in Q2 2022 and held it in 1 quarter.
  • Susquehanna International Group (Ireland)'s Genmab position peaked at $335K in Q2 2022.
  • 194 funds tracked by Wall St. Rank held Genmab as of Q3 2022.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q3 2022, filed 14 Nov 2022.